Table 4.
0–6 months | ΔFree T3 (0–6m) (n=528) | ΔTotal T3 (0–6m) (n=505) | ΔFree T4 (0–6m) (n=552) | ΔTotal T4 (0–6m) (n=499) | ΔTSH (0–6m) (n=547) |
---|---|---|---|---|---|
ΔWeight (0–6 m) | 0.29*** | 0.30*** | −0.05 | 0.06 | 0.05 |
ΔResting metabolic rate (0–6 m) | 0.24*** | 0.25*** | 0.03 | 0.04 | −0.04 |
ΔSystolic blood pressure (0–6 m) | 0.14** | 0.19*** | 0.04 | 0.07 | −0.02 |
ΔDiastolic blood pressure (0–6 m) | 0.14** | 0.20*** | 0.04 | 0.10* | 0.01 |
ΔGlucose (0–6 m) | 0.11* | 0.09* | 0.03 | 0.02 | −0.01 |
ΔInsulin (0–6 m) | 0.16*** | 0.20*** | −0.05 | 0.02 | −0.01 |
ΔTriglycerides (0–6 m) | 0.19*** | 0.23*** | −0.06 | 0.05 | 0.17*** |
ΔTotal cholesterol (0–6 m) | 0.03 | 0.03 | −0.02 | 0.05 | −0.03 |
ΔWhole body fat mass (0–6 m) † | 0.28*** | 0.33*** | 0.01 | 0.17* | 0.07 |
ΔWhole body lean mass (0–6 m) † | 0.21*** | 0.32*** | −0.09 | −0.004 | 0.07 |
ΔLeptin (0–6 m) | 0.17*** | 0.24*** | −0.13** | 0.03 | 0.09* |
ΔSoluble leptin receptor (0–6 m) | −0.08 | −0.06 | 0.06 | 0.12** | 0.03 |
| |||||
6–24 months | ΔFree T3 (0–6m) (n=448) | ΔTotal T3 (0–6m) (n=429) | ΔFree T4 (0–6m) (n=469) | ΔTotal T4 (0–6m) (n=424) | ΔTSH (0–6m) (n=465) |
| |||||
ΔWeight (6–24 m) | −0.03 | −0.006 | 0.06 | 0.05 | 0.09 |
ΔResting metabolic rate (6–24 m) | −0.08 | −0.02 | −0.002 | 0.03 | 0.08 |
ΔSystolic blood pressure (6–24 m) | −0.05 | −0.06 | −0.03 | −0.09 | 0.01 |
ΔDiastolic blood pressure (0–6 m) | −0.04 | −0.09 | −0.02 | −0.13* | −0.03 |
ΔGlucose (6–24 m) | 0.04 | 0.01 | 0.02 | 0.008 | −0.05 |
ΔInsulin (6–24 m) | 0.04 | 0.009 | 0.02 | 0.005 | −0.001 |
ΔTriglycerides (6–24 m) | −0.09 | −0.10* | 0.04 | −0.01 | 0.03 |
ΔCholesterol (6–24 m) | −0.10* | −0.10* | 0.01 | −0.05 | 0.07 |
ΔWhole body fat mass (6–24 m) † | −0.03 | 0.03 | 0.01 | 0.03 | 0.02 |
ΔWhole body lean mass (6–24 m) † | −0.07 | −0.007 | −0.06 | 0.004 | 0.09 |
ΔLeptin (6–24 m) | −0.07 | −0.11* | 0.07 | −0.05 | 0.11* |
ΔSoluble leptin receptor (6–24 m) | −0.003 | −0.04 | −0.02 | −0.11* | −0.10 |
| |||||
6–24 months | ΔFree T3 (6−24m) (n=415) | ΔTotal T3 (6−24m) (n=388) | ΔFree T4 (6−24m) (n=425) | ΔTotal T4 (6−24m) (n=377) | ΔTSH (6−24m) (n=422) |
| |||||
ΔWeight (6–24 m) | 0.25*** | 0.26*** | −0.13** | −0.005 | 0.04 |
ΔResting metabolic rate (6–24 m) | 0.15** | 0.18** | −0.09 | 0.03 | −0.01 |
ΔSystolic blood pressure (6–24 m) | 0.12* | 0.12* | −0.02 | 0.01 | 0.004 |
ΔDiastolic blood pressure (0–6 m) | 0.16** | 0.18*** | 0.01 | 0.11* | 0.08 |
ΔGlucose (6–24 m) | 0.04 | 0.05 | −0.004 | 0.01 | 0.04 |
ΔInsulin (6–24 m) | 0.09 | 0.14** | −0.13** | 0.005 | 0.03 |
ΔTriglycerides (6–24 m) | 0.14** | 0.15** | −0.12* | 0.06 | 0.03 |
ΔCholesterol (6–24 m) | 0.05 | −0.04 | −0.05 | 0.03 | 0.05 |
ΔWhole body fat mass (6–24 m) † | 0.29*** | 0.20* | −0.05 | 0.09 | 0.02 |
ΔWhole body lean mass (6–24 m) † | 0.14 | 0.18* | −0.22** | −0.08 | 0.02 |
ΔLeptin (6–24 m) | 0.23*** | 0.28*** | −0.09 | 0.07 | 0.04 |
ΔSoluble leptin receptor (6–24 m) | 0.01 | −0.03 | 0.17*** | 0.13* | 0.04 |
| |||||
0–24 months | ΔFree T3 (0–24m) (n=398) | ΔTotal T3 (0–24m) (n=369) | ΔFree T4 (0–24m) (n=420) | ΔTotal T4 (0–24m) (n=359) | ΔTSH (0–24m) (n=418) |
| |||||
ΔWeight (0–24 m) | 0.32*** | 0.41*** | −0.13** | 0.10 | 0.11 |
ΔResting metabolic rate (0–24 m) | 0.16** | 0.26*** | −0.03 | 0.12* | −0.02 |
ΔSystolic blood pressure (0–24 m) | 0.17*** | 0.19*** | −0.03 | 0.06 | −0.0003 |
ΔDiastolic blood pressure (0–6 m) | 0.17*** | 0.22*** | −0.02 | 0.09 | −0.003 |
ΔGlucose (0–24 m) | 0.17*** | 0.18*** | 0.004 | 0.10 | −0.07 |
ΔInsulin (0–24 m) | 0.24*** | 0.35*** | −0.09 | 0.14** | 0.03 |
ΔTriglycerides (0–24 m) | 0.14** | 0.16** | −0.13** | 0.07 | 0.15** |
ΔCholesterol (0–24 m) | 0.03 | −0.02 | 0.007 | 0.10 | 0.08 |
ΔWhole body fat mass (0–24 m) † | 0.34*** | 0.44*** | −0.02 | 0.24*** | 0.08 |
ΔWhole body lean mass (0–24 m) † | 0.24*** | 0.36*** | −0.20** | 0.09 | 0.12 |
ΔLeptin (0–24 m) | 0.20*** | 0.30*** | −0.12* | 0.07 | 0.20*** |
ΔSoluble leptin receptor (0–24 m) | −0.07 | −0.15** | 0.10* | 0.06 | −0.03 |
Values were adjusted for age, sex, race, education, smoking, alcohol consumption, physical activity, menopausal status, hormone replacement therapy, and diet groups. Δ= follow-up value –baseline value.
P<0.05;
P<0.01;
P<0.001;
further adjusted for whole body lean mass (for whole body fat mass) or whole body fat mass (for whole body lean mass); n=293 for 6 months, and n=177 for 24 months.